Lobe Sciences Announces Appointment of Mr. Mirza Rahimani, CPA, CA as Chief Financial Officer

Core Insights - Lobe Sciences Ltd. has appointed Mr. Mirza Rahimani as Chief Financial Officer effective March 2, 2026, following his role as a financial advisor since December 1, 2025 [1] - Mr. Rahimani brings over fifteen years of experience in finance, including accounting, financial reporting, corporate governance, and corporate development [1] - The company aims to advance therapeutic programs addressing significant unmet medical needs, with a focus on strategic development through its subsidiaries [1] Company Overview - Lobe Sciences Ltd. is a Canadian public biopharmaceutical company incorporated in British Columbia, with principal executive offices in Florida [1] - The company is pursuing programs in diseases with unmet medical needs and has a majority interest in Cynaptec Pharmaceuticals, Inc. and a wholly owned subsidiary, Applied Lipid Technologies, Inc. [1] Leadership Transition - Mr. Rahimani succeeds Mr. Yong Yao, who previously served as the Chief Financial Officer through an arrangement with Century Biolabs Inc. [1] - Dr. Frederick Sancilio, Chairman and CEO, expressed confidence in Mr. Rahimani's understanding of the company's strategy and operations, highlighting his extensive experience in public-company financial reporting and corporate governance [1]